Increased TIMP-2 levels are considered a favorable prognostic indicator in NSCLC, because they are correlated with the inhibition of endothelial cell proliferation and lung cancer cell angiogenesis in vivo [13]. This evidence concerns the gene TIMP2 and lung cancer.